Michael Deininger, M.D., Ph.D.
Associate Professor of Hematology/ Medical Oncology
Oregon Health & Science University
Joining OHSU in 2002, Dr. Deininger`s clinical interests concentrate on bone marrow transplantation and leukemia. His research focuses on the molecular basis of resistance to imatinib mesylate in patients with chronic myelogenous leukemia.